Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-10 8:36 pm Purchase | 2026-02-20 | 13G | Perspective Therapeutics, Inc. CATX | Avidity Partners Management LP | 6,049,999 5.300% | 3,208,975 (+112.95%) | Filing History |
| 2026-02-17 10:19 am Sale | 2025-12-31 | 13G | SCYNEXIS, Inc. SCYX | Avidity Partners Management LP | 4,426,565 9.900% | -90,192 (-2.00%) | Filing History |
| 2025-11-19 9:15 pm Sale | 2025-11-17 | 13D | Dianthus Therapeutics, Inc. DNTH | Avidity Partners Management LP | 2,104,184 4.900% | -1,274,755 (-37.73%) | Filing History |
| 2025-11-14 4:27 pm Purchase | 2025-09-30 | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 9,200,580 9.900% | 74,404 (+0.82%) | Filing History |
| 2025-11-14 2:27 pm Purchase | 2025-09-30 | 13G | SCYNEXIS, Inc. SCYX | Avidity Partners Management LP | 4,516,757 9.900% | 304,887 (+7.24%) | Filing History |
| 2025-11-14 1:39 pm Sale | 2025-09-30 | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 4,699,411 4.800% | -916,400 (-16.32%) | Filing History |
| 2025-11-14 1:33 pm Unchanged | 2025-09-30 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-14 2:37 pm Sale | 2025-06-30 | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 5,615,811 5.900% | -425,248 (-7.04%) | Filing History |
| 2025-08-14 2:28 pm Purchase | 2025-06-30 | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 9,126,176 9.900% | 1,349,880 (+17.36%) | Filing History |
| 2025-05-15 2:07 pm Sale | 2025-03-31 | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 6,041,059 6.600% | -2,981,304 (-33.04%) | Filing History |
| 2025-03-19 9:30 pm Purchase | 2025-03-17 | 13D | Dianthus Therapeutics, Inc. DNTH | Avidity Partners Management LP | 3,378,939 9.900% | 3,378,939 (New Position) | Filing History |
| 2025-02-14 10:42 am Purchase | 2024-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 502,600 6.900% | 502,600 (New Position) | Filing History |
| 2025-02-14 10:26 am Purchase | 2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX | Avidity Partners Management LP | 2,841,024 4.200% | 2,841,024 (New Position) | Filing History |
| 2025-02-14 10:21 am Purchase | 2024-12-31 | 13G | SCYNEXIS, Inc. SCYX | Avidity Partners Management LP | 4,211,870 9.900% | 4,211,870 (New Position) | Filing History |
| 2025-02-14 10:16 am Purchase | 2024-12-31 | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 9,022,363 9.900% | 9,022,363 (New Position) | Filing History |
| 2025-02-14 10:10 am Purchase | 2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Avidity Partners Management LP | 2,048,020 7.600% | 2,048,020 (New Position) | Filing History |
| 2025-02-14 10:02 am Purchase | 2024-12-31 | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 7,776,296 9.900% | 7,776,296 (New Position) | Filing History |
| 2024-12-03 9:19 pm Unchanged | 2024-12-03 | 13D | Dianthus Therapeutics, Inc. DNTH | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 7:38 pm Unchanged | 2024-11-14 | 13G | Oruka Therapeutics, Inc. ORKA | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 7:07 pm Unchanged | 2024-11-14 | 13G | SCYNEXIS, Inc. SCYX | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing |